So, the natural question for Surrozen (NASDAQ:SRZN) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted ...

Fintel reports that on January 3, 2025, Guggenheim upgraded their outlook for Surrozen (NasdaqCM:SRZN) from Neutral to Buy. Analyst Price Forecast Suggests 136.21% Upside As of December 23 ...

Check the time stamp on this data. Updated AI-Generated Signals for Surrozen Inc. (SRZN) available here: SRZN. Type a few ...

Guggenheim analyst Yatin Suneja upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Discover the latest stocks recommended by top Wall Street analysts, all in one place with ...

As previously reported, Guggenheim upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Recent Phase 1b data for SZN-043, the company’s lead asset for liver disease, was ...

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s ...

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

As of December 23, 2024, the average one-year price target for Surrozen is $33.66/share. The forecasts range from a low of $33.33 to a high of $34.65. The average price target represents an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...